therapeutically targeting transcription factors in cll
Published 6 years ago • 228 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:26
using transcription factors as therapeutic targets in mm
-
2:01
transcription factor foxo1 mediates cell survival during bcr inhibitor therapy in cll
-
1:00
identifying new cll therapeutic targets by focusing on the evolution of cancer cells
-
1:24
sequencing of btk inhibitors in cll
-
1:33
key factors affecting treatment decision making in cll
-
3:41
personalised medicine in cll: redefining the treatment approach
-
2:13
resistance mechanisms in cll and the importance of genomic re-testing
-
2:02
important prognostic factors to evaluate in cll patients in the era of small molecules
-
7:50
cd28_ amplifying t cell responses for better tumor clearance
-
3:33
mbl: low vs. high count and cll progression
-
22:05
kprc news opens
-
2:21
targeting b-cell receptor signaling with btk degraders to treat cll
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
2:23
the importance of genomic testing in cll in the era of novel therapies
-
5:21
examples of biology informing treatment decisions in cll
-
2:36
changing epigenetic markers in cll patients on ibrutinib
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
0:36
the use of ai for analyzing genetic and molecular data in cll
-
3:50
relevance of current prognostication and prediction markers for cll with new targeted therapies
-
1:36
the importance of genomic testing when making treatment decisions in cll
-
1:00
using molecular features to determine appropriate treatment strategies for patients with cll
-
1:28
genomic testing in cll